Eccrine hidrocystoma
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Ọ na-egosi dị ka obere papules na-acha anụnụ anụnụ juputara na mmiri mmiri doro anya.
References
Eccrine hidrocystomas (EHs) bụ etuto ahụ na-adịghị mma nke na-etolite site na ọsụsọ eccrine fụrụ akpụ. Ha na-adịru ogologo oge ma nwee ike ịka njọ n'oge ihu igwe na-ekpo ọkụ mgbe ọsụsọ na-abawanye. A na-achọpụtakarị EH dabere na mgbaàmà, mana biopsy akpụkpọ ahụ nwere ike kwado ya. Anyị na-eweta ikpe abụọ nke EH, na-elekwasị anya na njirimara dermoscopic ha na ọgwụgwọ na-aga nke ọma na nsị botulinum toxin dị ka peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
Eccrine hidrocystomas (EHs) are benign tumors, which arise as cystic dilatation of the eccrine sweat duct. The lesions of EH have a chronic course with periodic flares in summer months, associated with exacerbation in sweating. Diagnosis is mainly clinical with histopathology being confirmatory. Dermoscopy is a noninvasive tool, which may confirm diagnosis of EH without subjecting the patient to a biopsy. We report two representative cases of EH, with emphasis on dermoscopic features and which well responded to topical botulinum toxin-like peptide.
○ Ọgwụgwọ
Idochi ebe emetụtara nwere ike belata obere oge nke mpaghara emetụtara.
Ọgwụgwọ laser anaghị adị irè.